P Libert

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

Marianne Paesmans, Jean‐Paul Sculier, P Libert et al. · Journal of Clinical Oncology · 1995 · 394 citations

Medicine, Biostatistics, Oncology +17

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

Jean Klášterský, Jean‐Paul Sculier, H. Lacroix et al. · Journal of Clinical Oncology · 1990 · 247 citations

Medicine, Oncology, Pharmacology +13

Prognostic factors for patients with small cell lung carcinoma

Marianne Paesmans, Jean‐Paul Sculier, J. Lecomte et al. · Cancer · 2000 · 221 citations

Medicine, Oncology, Chemotherapy +14

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.

Jean Klášterský, Jean‐Paul Sculier, P Ravez et al. · Journal of Clinical Oncology · 1986 · 136 citations

Medicine, Oncology, Pharmacology +15

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.

Jean Klášterský, Jean‐Paul Sculier, G. Bureau et al. · Journal of Clinical Oncology · 1989 · 131 citations

Medicine, Oncology, Pharmacology +14